Changes in the gut mycobiome in pediatric patients in relation to the clinical activity of Crohn's disease

被引:0
|
作者
Agnieszka Krawczyk [1 ]
Dominika Salamon [1 ]
Kinga Kowalska-Duplaga [2 ]
Barbara Zapa?a [3 ]
Teofila Ksi??ek [4 ]
Marta Dra?niuk-Warcho? [5 ]
Tomasz Gosiewski [1 ]
机构
[1] Department of Microbiology Division of Molecular Medical Microbiology,Jagiellonian University Medical College
[2] Department of Pediatrics,Gastroenterology and Nutrition,Jagiellonian University Medical College
[3] Department of Clinical Biochemistry,Jagiellonian University Medical College
[4] Department of Medical Genetics,Jagiellonian University Medical College
[5] Department of Pediatrics,Gastroenterology and Nutrition,University Children's Hospital
关键词
D O I
暂无
中图分类号
R725.7 [小儿消化系及腹部疾病];
学科分类号
100202 ;
摘要
BACKGROUND Numerous studies have shown that in Crohn’s disease(CD), the gut microbiota is of great importance in the induction and maintenance of inflammation in the gastrointestinal tract. Until recently, studies have focused almost exclusively on bacteria in the gut. Lately, more attention has been paid to the role of intestinal fungi.AIM To study the gut mycobiome analysis of pediatric patients with CD(in different stages of disease activity) compared to healthy children.METHODS Fecal samples were collected from patients: With active, newly diagnosed CD(n = 50); active but previously diagnosed and treated CD(n = 16); non-active CD and who were in clinical remission(n = 39) and from healthy volunteers(n = 40).Fungal DNA was isolated from the samples. Next, next generation sequencing(MiSeq, Illumina) was performed. The composition of mycobiota was correlated with clinical and blood parameters.RESULTS Candida spp. were overrepresented in CD patients, while in the control group, the most abundant genus was Saccharomyces. In CD patients, the percentage of Malassezia was almost twice that of the control(P < 0.05). In active CD patients, we documented a higher abundance of Debaryomyces hansenii(D. hansenii) compared to the non-active CD and control(P < 0.05) groups. Moreover, statistically significant changes in the abundance of Mycosphaerella, Rhodotorula, and Microidium were observed. The analyses at the species level and linear discriminant analysis showed that in each group it was possible to distinguish a specific species characteristic of a given patient population. Moreover, we have documented statistically significant correlations between: D. hansenii and patient age(negative); C. zeylanoides and patient age(positive); C. dubliniensis and calprotectin(positive); C. sake and calprotectin(positive); and C. tropicalis and pediatric CD activity index(PCDAI)(positive).CONCLUSION Mycobiome changes in CD patients, and the positive correlation of some species with calprotectin or PCDAI, give strong evidence that fungi may be of key importance in the development of CD.
引用
收藏
页码:2172 / 2187
页数:16
相关论文
共 50 条
  • [1] Changes in the gut mycobiome in pediatric patients in relation to the clinical activity of Crohn's disease
    Krawczyk, Agnieszka
    Salamon, Dominika
    Kowalska-Duplaga, Kinga
    Zapala, Barbara
    Ksiazek, Teofila
    Drazniuk-Warchol, Marta
    Gosiewski, Tomasz
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (14) : 2172 - 2187
  • [2] Evidence of Disturbed Gut Microbial Metabolic Activity in Pediatric Crohn's Disease
    Sundqvist, Tommy
    Stenhammar, Lars
    Tjellstrom, Bo
    Magnusson, Karl-Eric
    Midtvedt, Tore
    Norin, Elisabeth
    Hogberg, Lotta
    [J]. CROHNS & COLITIS 360, 2019, 1 (01)
  • [3] The Gut Mycobiome in Parkinson's Disease
    Cirstea, Mihai S.
    Sundvick, Kristen
    Golz, Ella
    Yu, Adam C.
    Boutin, Rozlyn C. T.
    Kliger, Daniel
    Finlay, Brett B.
    Appel-Cresswell, Silke
    [J]. JOURNAL OF PARKINSONS DISEASE, 2021, 11 (01) : 153 - 158
  • [4] ULCERATIONS AND CROHN'S DISEASE ACTIVITY INDEX IN PEDIATRIC PATIENTS
    Saleh, R.
    Raftery, T.
    Broderick, A.
    Bourke, B.
    Hussey, S.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S24 - S24
  • [5] Relation Between Sleep and Disease Activity in Depressed Pediatric Patients With Crohn Disease Response
    Benhayon, David
    Youk, Ada
    McCarthy, F. Nicole
    Davis, Stephanie
    Keljo, David J.
    Bousvaros, Athos
    Fairclough, Diane
    Kupfer, David
    Buysse, Daniel J.
    Szigethy, Eva M.
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2014, 58 (05): : E51 - E51
  • [6] Pediatric Crohn's disease patients
    Pittschieler, K.
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 2006, 154 (11) : 1124 - 1124
  • [7] CHARACTERIZATION OF THE EFFECT OF NUTRITIONAL THERAPIES ON GUT METABOLITES COMPOSITION IN PROSPECTIVE CLINICAL TRIAL OF PEDIATRIC CROHN'S DISEASE PATIENTS
    Ghiboub, Mohammed
    Penny, Susanne
    Verburgt, Charlotte M.
    Boneh, Rotem S.
    Wine, Eytan
    Cohen, Alejandro
    Dunn, Katherine A.
    Devanand, Pinto
    Benninga, Marc A.
    De Jonge, Wouter J.
    Levine, Arie
    van Limbergen, Johan
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S725 - S725
  • [8] Clinical characteristics of 320 pediatric Crohn's disease patients registered in the nationwide Crohn's disease registry in Poland
    Kierkus, Jaroslaw
    Sladek, Malgorzata
    Pytrus, Tomasz
    Landowski, Piotr
    Czaja-Bulsa, Grazyna
    Ignys, Iwona
    Mierzwa, Grazyna
    Grzybowska-Chlebowczyk, Urszula
    Czkwianianc, Elzbieta
    Zabke, Alicja
    Rydzewska, Grazyna
    [J]. PRZEGLAD GASTROENTEROLOGICZNY, 2012, 7 (04): : 228 - 232
  • [9] Clusters of Disease Activity and Early Risk Factors of Clinical Course of Pediatric Crohn's Disease
    Distante, Manuela
    Rotulo, Silvia
    Ranalli, Marco
    Pedace, Eugenio
    Lionetti, Paolo
    Arrigo, Serena
    Alvisi, Patrizia
    Miele, Erasmo
    Martinelli, Massimo
    Zuin, Giovanna
    Bramuzzo, Matteo
    Cananzi, Mara
    Aloi, Marina
    [J]. INFLAMMATORY BOWEL DISEASES, 2023,
  • [10] Menarche in Pediatric Patients With Crohn's Disease
    Gupta, Neera
    Lustig, Robert H.
    Kohn, Michael
    Vittinghoff, Eric
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S513 - S514